# Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot)

> **NCT04160117** · PHASE3 · COMPLETED · sponsor: **Population Health Research Institute** · enrollment: 202 (actual)

## Conditions studied

- Atrial Fibrillation
- Recurrence

## Interventions

- **DRUG:** Colchicine 0.6 mg
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT04160117
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-14
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04160117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04160117, "Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04160117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*